| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | MRE-269 β-D-Glucuronide |
|---|
| Description | MRE-269 β-D-Glucuronide can be obtained from 4-Amino-1-butanol (A602120) which is used in the synthesis of NSAIDs with anti-inflammatory properties.4-Amino-1-butanol (A602120) is also used in the synthesis of polyamine transport ligands with specificity against human cancers allowing easy access to specific cancer cells. MRE-269 β-D-Glucuronide is Glucuronide metabolite of Selexipag (S253150). The drug is first hydrolyzed to an active metabolite, ACT 33679 (CAS#475085-57-5, planned) in the liver and then glucuronidated afterwards. Molecular Formula: C31H37N3O9 Molecular Weight: 595.64 |
|---|
| Size | 1mg, 5mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 456639 |
|---|
| Price | |
|---|
| Order / More Info | MRE-269 β-D-Glucuronide from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|